For the development of a multivariate prediction model for risk stratification of COVID-19 patients, the established clinical score CRB-65 and biomarkers TnThs, PCT, ET-1, Ang-2, NT-proBNP, copeptin and lipocalin-2 were considered. This evidence concerns the gene LCN2 and COVID-19.